Streamline Health Solutions, Inc. (STRM)

STRM Income Statement

Financials in millions USD. Fiscal year is February - January.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Apr 30, 2025	Jan 31, 2025	Jan 31, 2024	Jan 31, 2023	Jan 31, 2022	Jan 31, 2021
Revenue	18.38	17.9	22.6	24.89	17.38	11.35
Revenue Growth (YoY)	-14.88%	-20.78%	-9.21%	43.21%	53.17%	-4.28%
Cost of Revenue	9.51	9.56	11.05	13.4	8.58	5.69
Gross Profit	8.88	8.34	11.54	11.49	8.8	5.66
Selling, General & Admin	11.34	11.74	14.71	16.28	11.93	8.57
Research & Development	4.42	4.63	5.7	6.04	4.78	2.93
Operating Expenses	15.77	16.37	20.41	22.33	16.71	11.5
Operating Income	-6.89	-8.03	-8.87	-10.83	-7.91	-5.84
Interest Expense	-2.09	-2.01	-1.07	-0.75	-0.24	-0.05
Other Non Operating Income (Expenses)	-0	-0	0.03	0.2	0.06	-0.06
EBT Excluding Unusual Items	-8.98	-10.04	-9.91	-11.38	-8.09	-5.95
Merger & Restructuring Charges	0.01	-	-	-	-2.86	-
Impairment of Goodwill	-	-	-9.81	-	-	-
Asset Writedown	-	-	-0.96	-	-	-
Other Unusual Items	-0.09	-0.12	1.94	0.07	4.14	-0.11
Pretax Income	-9.07	-10.16	-18.74	-11.31	-6.81	-6.06
Income Tax Expense	-	-	-0.05	0.07	0.11	-1.26
Earnings From Continuing Operations	-9.07	-10.16	-18.7	-11.38	-6.92	-4.8
Earnings From Discontinued Operations	-	-	-	-	0.38	5.1
Net Income	-9.07	-10.16	-18.7	-11.38	-6.54	0.3
Net Income to Common	-9.07	-10.16	-18.7	-11.38	-6.54	0.3
Shares Outstanding (Basic)	4	4	4	3	3	2
Shares Outstanding (Diluted)	4	4	4	3	3	2
Shares Change (YoY)	6.98%	6.41%	14.57%	13.98%	41.23%	22.16%
EPS (Basic)	-2.23	-2.53	-4.96	-3.46	-2.29	0.15
EPS (Diluted)	-2.23	-2.53	-4.96	-3.46	-2.29	0.09
Free Cash Flow	-1.29	-1.52	-2.27	-7.15	-3.55	-5.8
Free Cash Flow Per Share	-0.32	-0.38	-0.60	-2.17	-1.23	-2.84
Gross Margin	48.29%	46.58%	51.08%	46.18%	50.65%	49.86%
Operating Margin	-37.48%	-44.85%	-39.26%	-43.52%	-45.52%	-51.48%
Profit Margin	-49.32%	-56.75%	-82.75%	-45.72%	-37.64%	2.61%
Free Cash Flow Margin	-7.02%	-8.50%	-10.04%	-28.74%	-20.40%	-51.13%
EBITDA	-5.49	-6.55	-7.67	-9.44	-6.89	-5.29
EBITDA Margin	-29.85%	-36.58%	-33.96%	-37.91%	-39.63%	-46.59%
D&A For EBITDA	1.4	1.48	1.2	1.4	1.02	0.56
EBIT	-6.89	-8.03	-8.87	-10.83	-7.91	-5.84
EBIT Margin	-37.48%	-44.85%	-39.26%	-43.52%	-45.52%	-51.48%
Revenue as Reported	18.38	17.9	22.6	24.89	17.38	11.35

Updated May 2, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q